OBJECTIVE: Available data on clinical outcomes of hybrid aortic arch repair are limited,
especially for patients with aortic dissection. The objective of this review was to provide …

Background—Thoracic endovascular aortic repair (TEVAR) represents a therapeutic
concept for type B aortic dissection. Long-term outcomes and morphology after TEVAR for …

The utility of Thoracic EndoVascular Aortic Repair (TEVAR) continues to progress at a very
rapid rate. Initially implemented for the treatment of thoracic aortic aneurysms, TEVAR has …

OBJECTIVE: Open total arch procedures have been associated with significant morbidity
and mortality in patients with multiple comorbidities. Aortic arch debranching with …

OBJECTIVE: Retrograde ascending aortic dissection (rAAD) is a potential complication of
thoracic endovascular aortic repair (TEVAR), yet little data exist regarding its occurrence …

Introduction Despite a current lack of US Food and Drug Administration approval for the
indication, thoracic endovascular aortic repair (TEVAR) has replaced open surgical …

BACKGROUND: Thoracic endovascular aortic repair (TEVAR) for the management of type B
aortic dissections has become more commonplace despite some controversy. Results of …

OBJECTIVE: Thoracic endovascular aortic repair for chronic type B aortic dissection with
associated descending thoracic aneurysm remains controversial. Concerns include …

Objective Since thoracic endovascular aortic repair (TEVAR) received US Food and Drug
Administration approval for the treatment of descending thoracic aneurysms in March 2005 …

Background The need for routine left subclavian artery (LSCA) revascularization when this
vessel is covered during thoracic endovascular aortic repair remains controversial. We …